MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.biologicals.2024.101784

Медицинская библиотека · Biologicals : journal of the International Association of Biological Standardization · 2024

Current trends in development and manufacturing of higher-valent pneumococcal polysaccharide conjugate vaccine and its challenges.

Jain Shital S, Singh Vikas K, Kante Rajesh Kumar, Jana Swapan Kumar, Patil Rajendra H

СтатьяОбзорПеревод в очереди

Аннотация

Pneumococcal conjugate vaccines (PCVs) have been developed to protect against pneumococcal diseases caused by the more than 100 serotypes of the bacterium Streptococcus pneumoniae. PCVs primarily prevent pneumococcal infections such as sepsis, bacteraemia, meningitis, otitis media, pneumonia, septicaemia, and sinusitis among infants, adults, elderly, and immunocompromised individuals. The current available PCVs only cover a limited number of serotypes, and there is an immense need for developing higher-valent PCVs that can protect against non-vaccine serotypes to overcome challenges like serotype replacement and antibiotic resistance. The main challenges for developing higher valent PCVs are the complexity of the manufacturing process comprising polysaccharide fermentation, purification, modification or sizing of multiple polysaccharides and conjugation between polysaccharides and carrier proteins, the stability of the conjugates, and the immunogenicity of the vaccine. Different manufacturing processes have been explored to produce higher valent PCVs using different serotypes of S. pneumoniae and conjugation with different carrier proteins. The global coverage of higher valent PCVs are still low, mainly due to the high cost and limited supply of the vaccine. This review focuses on the existing and emerging manufacturing processes and challenges associated with higher-valent pneumococcal PCV development.

Для цитирования: Jain Shital S, Singh Vikas K, Kante Rajesh Kumar, Jana Swapan Kumar, Patil Rajendra H. Current trends in development and manufacturing of higher-valent pneumococcal polysaccharide conjugate vaccine and its challenges.. Biologicals : journal of the International Association of Biological Standardization. 2024. DOI: 10.1016/j.biologicals.2024.101784.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.